Jerzy Alfred Leszczynski

Jerzy Alfred Leszczynski is a declared insider of Helix BioPharma Corp., with filings sourced from SEDI. In total, 4 filings cover trades dated from 18 April 2022 to 16 August 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 21 August 2024, reports a transaction in Helix BioPharma Corp. Filings reach the SEDI feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.